Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 584

recruiting
3 983
countries
28
conditions
2 109

10 385 trials match your criteria

Study on the Effectiveness and Safety of Reparixin for Adults with Acute Respiratory Distress Syndrome

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years

Study on Adding Nivolumab to Cisplatin and Radiotherapy for High-Risk Patients with Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years

Asthma+1

Not recruiting

Study on the Effects of ARO-MUC5AC Inhalation Solution for Patients with Asthma and COPD

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years

Study on Osimertinib and Savolitinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Osimertinib Treatment

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years

Chronic hepatitis B

Not recruiting

Study on the Safety and Effectiveness of Terbinafine for Patients with Chronic Hepatitis B

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years

Study on Long-Term Safety and Effectiveness of Liposomal Ciclosporin A for Patients with Bronchiolitis Obliterans Syndrome After Lung Transplantation

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Ciclosporin A

Study of ponatinib and azacitidine combination treatment in patients with accelerated phase or blast crisis chronic myelogenous leukemia

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Depression+1

Not recruiting

Study on the Effects of Etifoxine in Treating Depression in Patients with Unipolar or Bipolar Disorder

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years

Study on the Safety and Effectiveness of Utreglutide (GL0034) for Adults with Type 2 Diabetes Not Well Managed with Metformin or Lifestyle Changes

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years

Study for Adults with Very High-Risk T-Cell Acute Lymphoblastic Leukemia Using Daratumumab and a Drug Combination

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Aciclovir
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.